Stem Cell Transplantation Still the Main Treatment Option for Beta-Thalassemia

Watchdoq December 27, 2024
(MedPage Today) -- While gene therapy has emerged as a promising alternative for treating beta-thalassemia, hematopoietic stem cell transplantation (HSCT) remains the only widely accessible curative option for this inherited blood disorder.
"The...

Read Full Article